PREVENTION AND TREATMENT OF ALZHEIMER'S DISEASE THROUGH ELECTROMAGNETIC FIELD EXPOSURE

• US 20120065456A1
• Filed: 09/12/2011
• Published: 03/15/2012
• Est. Priority Date: 03/11/2009
• Status: Active Grant

• Current Assignee: University of South Florida (State University System of Florida), The United States of America as represented by the Department of Veterans Affairs, Office of the Gen
• Original Assignee: University of South Florida (State University System of Florida)
• Inventors: Arendash, Gary W., Tan, Jun, Cao, Chuanhai
• Granted Patent: US 9,238,149 B2
• Time in Patent Office: Days
• US Class Current: 600/13
• CPC Class Codes: A61N 2/006 for magnetic stimulation of nerve tissue
• CPC Class Codes: A61N 2/02 using magnetic fields produced by coils, including single turn loops or electromagnets A61N2/12 takes precedence
• CPC Class Codes: A61N 5/02 using microwaves

Abstract

The invention includes a method of treating and preventing a neurological disorder, such as Alzheimer'"'"'s Disease, in a subject in need thereof by positioning an electromagnetic field emitting source proximal to the subject and exposing the subject to an electromagnetic field having a predetermined frequency for a predetermined absorption period. Preferably, each individual treatment (comprising exposure to the predetermined frequency for the predetermined absorption period) is continued at a predetermined schedule (preferably daily) for a predetermined treatment period.

The predetermined frequency, according to a preferred embodiment, is about 918 MHz with a specific absorption rate (SAR) of about 0.25 W/kg+/−2 dB. The predetermined absorption period of this preferred embodiment is about one hour. The treatment period is long-term, being greater than about 6 months and preferably between about 7 and 9 months.

Claims

1. A method of treating Alzheimer'"'"'s Disease in a subject in need thereof comprising:

positioning an electromagnetic field emitting source proximal to the subject;

exposing the subject to an electromagnetic field having a predetermined frequency for a predetermined absorption period; and

continuing exposure to the subject for the predetermined absorption period for a predetermined treatment period.

2. The method of claim 1, wherein the predetermined frequency is about 918 MHz.

3. The method of claim 1, wherein the electromagnetic field has a specific absorption rate of about 0.25 W/kg.

4. The method of claim 1, wherein the predetermined absorption period is about one hour twice daily.

5. The method of claim 1, wherein the predetermined treatment period is greater than about 6 months.

6. The method of claim 1, wherein the predetermined treatment period is between about 7 and 9 months.

7. The method of claim 1, wherein the EMF is non-pulsed and unmodulated.

8. A method of preventing an amyloid-related neurological disorder in a subject at risk thereof, comprising:

positioning an electromagnetic field emitting source proximal to the subject;

exposing the subject to an electromagnetic field having a predetermined frequency for a predetermined absorption period; and

continuing exposure to the subject for the predetermined absorption period for a predetermined treatment period.

9. The method of claim 8, wherein the predetermined frequency is about 918 MHz.

10. The method of claim 8, wherein the electromagnetic field has a specific absorption rate of about 0.25 W/kg.

11. The method of claim 8, wherein the predetermined absorption period is about one hour twice daily.

12. The method of claim 8, wherein the predetermined treatment period is greater than about 6 months.

13. The method of claim 8, wherein the predetermined treatment period is between about 7 and 9 months.

14. The method of claim 8, wherein the EMF is non-pulsed and unmodulated.